...
首页> 外文期刊>Molecular oral microbiology >Identification of amino acid residues involved in hemin binding in Porphyromonas gingivalis hemagglutinin 2
【24h】

Identification of amino acid residues involved in hemin binding in Porphyromonas gingivalis hemagglutinin 2

机译:牙龈卟啉单胞菌血凝素2中涉及血红素结合的氨基酸残基的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Porphyromonas gingivalis (P. gingivalis) is a major etiological agent in the development and progression of chronic periodontitis. It produces cysteine proteases (gingipains), including a lysine-specific gingipain and two arginine-specific gingipains. Heme binding and uptake are fundamental to the growth and virulence of P.gingivalis. The recombinant hemagglutinin 2 domain (rHA2) of gingipain binds hemin with high affinity. The aim of the present work was to identify the key residues involved in its hemin-binding activity. A functional rHA2 was expressed and bound to hemin-agarose, and then digested with endopeptidases. The peptides bound to hemin-agarose were identified by mass spectrometry and the amino acids were assessed by mutation and peptide binding inhibition analysis. The DHYAVMISK sequence was identified in peptides derived from both Asp-N and Lys-C endopeptidase digestions of rHA2. A monoclonal antibody, mAb QB, was produced and its epitope was associated with the DGFPGDHYAVMISK peptide within the HA2 domain. Hemin was shown to competitively inhibit the immunoreactivity of rHA2 or the peptide to mAb QB. The peptide DHYAVMISK inhibited hemin-binding activity; although, this inhibition was not seen when the peptide contained the H1001E mutation (DEYAVMISK). Based on these results, we propose that residue His1001 is involved in the hemin-binding mechanism of the P.gingivalis rHA2 and the peptide containing this residue, DHYAVMISK, may be an inhibitor of hemin binding.
机译:牙龈卟啉单胞菌(P. gingivalis)是慢性牙周炎发生和发展的主要病因。它产生半胱氨酸蛋白酶(姜黄素),包括赖氨酸特异性姜黄素和两个精氨酸特异性姜黄素。血红素的结合和摄取对牙龈卟啉单胞菌的生长和毒力至关重要。姜黄素的重组血凝素2结构域(rHA2)以高亲和力结合血红素。本工作的目的是鉴定参与其血红素结合活性的关键残基。表达功能性rHA2并与血红素琼脂糖结合,然后用内肽酶消化。通过质谱鉴定与血红素-琼脂糖结合的肽,并通过突变和肽结合抑制分析评估氨基酸。在源自rHA2的Asp-N和Lys-C内肽酶消化的肽中鉴定了DHYAVMISK序列。产生了单克隆抗体mAb QB,其表位与HA2结构域中的DGFPGDHYAVMISK肽相关。血红素显示出竞争性抑制rHA2或肽对mAb QB的免疫反应性。肽DHYAVMISK抑制血红素结合活性。但是,当该肽含有H1001E突变(DEYAVMISK)时,看不到这种抑制作用。根据这些结果,我们提出残基His1001参与牙龈卟啉单胞菌rHA2的血红素结合机制,而含有该残基的肽DHYAVMISK可能是血红素结合的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号